INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2016

Edible marijuana exposures reported to US poison centers increased from 2013 to 2015, with drowsiness, tachycardia, and rare intubations documented.

Researchers analyzed 430 single-substance human exposure calls regarding edible marijuana products reported to the US National Poison Data System from January 2013 to December 2015. Calls increased each year, with the highest numbers in Colorado (n=166) and Washington (n=96), and 91% occurring in states with decriminalized medical/recreational marijuana. The most common age groups were ≤5 years (n=109) and 13–19 years (n=78). Frequent clinical effects included drowsiness/lethargy (43%), tachycardia (31%), agitation/irritability (14%), and confusion (14%). Common therapies included intravenous fluids (20%), dilute/irrigate/wash (11%), and benzodiazepines (11%). Three patients (ages 4, 10, and 57 years) required intubation, while no deaths were reported.

Shows an association, not proof of cause and effect.

Study type
Retrospective poison center registry analysis
Who was studied
430 single-substance human exposure calls related to edible marijuana products
What was measured
Clinical effects, therapies administered, and level of healthcare utilization

THE PAPER

Characterization of edible marijuana product exposures reported to United States poison centers.

Cao D, Srisuma S, Bronstein AC, Hoyte CO. Clin Toxicol (Phila), 2016.

PubMed 27418198 ↗DOI 10.1080/15563650.2016.1209761 ↗

Food safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.